Alliancebernstein L.P. Procept Bio Robotics Corp Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 2,143,693 shares of PRCT stock, worth $129 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,143,693
Previous 1,752,478
22.32%
Holding current value
$129 Million
Previous $141 Million
11.49%
% of portfolio
0.05%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
301Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$310 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$211 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$85.5 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$71.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$71.5 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.69B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...